Acomplia - FDA Reject?

Acomplia was supposed to be the miracle drug obese American were looking for, but Americans will not be getting Acomplia any time soon, if at all. That is because a FDA advisory committee just unanimously rejected the drug.

What is Acomplia?

Acomplia is the first CB1 cannabinoid receptor blocker. The CB1 receptor is in your brain. Blocking this receptor results in a decrease in appetite. Take the pill, you eat less and lose weight. This drug is for obese individuals and has been proven to work at decreasing weight.

Acomplia is made by Sanofi-Aventis and has been approved in over 35 countries. Unfortunately, having to sell it in those countries and not the US is like having to go to the prom with your cousin. It is just not ideal. Americans are the largest people in the world and we spend more on prescription medications than anyone.

What is wrong with Acomplia?

Acomplia was rejected because of its potential side effects. It seems that blocking the CB1 receptor does more than just suppress your appetite. It also causes depression and anxiety in some people. Most people would be happy if they lost some weight, but this drug may make you sad while you lose weight. Sounds like fun.

The future

The drug will probably be officially rejected by the FDA and Sanofi will have to try again. Americans are going to have to lose weight the old fashion way, using a well balance low calorie diet and exercise. It is a good thing you have Dr. Kal's Blog to help you out.

Sources:
The New York Times
The Diet Blog

Start losing weight today without breaking the bank using Dr. Kal's Don't Go Broke Diet.

Laugh and lose weight at the Laugh Out Loud Weight Loss Blog.

Return to Dr. Kal's Weight Loss Blog Main Page

**Please consult your physician, registered dietitian, or certified fitness professional before starting or changing your diet or exercise program.**